The cannabinoid system and pain

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuropharmacology

• Publication date

  2017-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2017.06.015PMID 28625720PMCID PMC5785108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterisation of peroxisome proliferator-activated receptor signalling in the midbrain periaqueductal grey of rats genetically prone to heightened stress, negative affect and hyperalgesia

  2019cited by this paper
• A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee

  2019cited by this paper
• Positive allosteric modulation of CB1 suppresses pathological pain without producing tolerance or dependence

  2018cited by this paper
• The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nocicpetive tone Running title: Endocannabinoids, PAG and conditional analgesia

  2017cited by this paper
• Characterisation of peroxisome proliferator-activated receptor signalling in the midbrain periaqueductal grey of rats genetically prone to heightened stress, negative affect and hyperalgesia.

  2017cited by this paper
• Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor.

  2017cited by this paper
• Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.

  2017cited by this paper
• Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.

  2017influential reference
• The endocannabinoid hydrolysis inhibitor SA‐57: Intrinsic antinociceptive effects, augmented morphine‐induced antinociception, and attenuated heroin seeking behavior in mice

  2017cited by this paper
• Report by the Temporary Specialist Scientific Committee (TSSC), "FAAH (Fatty Acid Amide Hydrolase)", on the causes of the accident during a Phase 1 clinical trial

  2016cited by this paper
• Cyclooxygenase-2 inhibition reduces stress-induced affective pathology

  2016cited by this paper
• Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains.

  2016influential reference
• Towards a mechanism-based approach to pain diagnosis

  2016cited by this paper
• The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.

  2016cited by this paper
• An update on PPAR activation by cannabinoids

  2016cited by this paper
• What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials

  2016cited by this paper
• Lessons from the fatal French study BIA-10-2474

  2016cited by this paper
• Genotype-dependent responsivity to inflammatory pain: A role for TRPV1 in the periaqueductal grey.

  2016influential reference
• Lessons from the fatal French study BIA-10-2474

  2016cited by this paper
• Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model

  2016cited by this paper
• Neurobiological Interactions Between Stress and the Endocannabinoid System

  2016cited by this paper
• A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase

  2016influential reference
• The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model

  2016cited by this paper
• Specific Targeting of the Basolateral Amygdala to Projectionally Defined Pyramidal Neurons in Prelimbic and Infralimbic Cortex

  2016cited by this paper
• Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers

  2016cited by this paper
• Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats

  2016influential reference
• Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms

  2015cited by this paper
• Neuroinflammatory Mechanisms Linking Pain and Depression.

  2015cited by this paper
• Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.

  2015cited by this paper
• A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis

  2015cited by this paper
• Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety

  2015cited by this paper
• The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

  2015cited by this paper
• Estimates of pain prevalence and severity in adults: United States, 2012.

  2015cited by this paper
• Role of Prelimbic GABAergic Circuits in Sensory and Emotional Aspects of Neuropathic Pain.

  2015influential reference
• Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage

  2015cited by this paper
• Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.

  2015cited by this paper
• Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release

  2015cited by this paper
• The role of the endocannabinoid system in pain.

  2015cited by this paper
• Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain

  2015influential reference
• Endocannabinoids and Mental Disorders.

  2015cited by this paper
• Full FAAH inhibition combined with partial monoacylglycerol lipase inhibition: Augmented and sustained antinociceptive effects with reduced cannabimimetic side effects in mice

  2015influential reference
• Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice

  2015influential reference
• Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice

  2015influential reference
• Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety

  2015cited by this paper
• A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

  2015cited by this paper
• Amygdala pain mechanisms.

  2015influential reference
• Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety‐like behavior

  2015cited by this paper
• High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity

  2015cited by this paper
• Selective monoacylglycerol lipase inhibitors: Antinociceptive vs. cannabimimetic effects in mice

  2015influential reference
• Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord

  2014influential reference
• CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model

  2014cited by this paper
• Harnessing the anti-inflammatory potential of palmitoylethanolamide.

  2014cited by this paper
• Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia

  2014cited by this paper
• Stress-induced hyperalgesia.

  2014cited by this paper
• Neurobiology of stress-induced hyperalgesia.

  2014cited by this paper
• Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.

  2014cited by this paper
• Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca2+-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus

  2014cited by this paper
• Long-range connectivity defines behavioral specificity of amygdala neurons.

  2014cited by this paper
• Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype‐dependent hyper‐responsivity to noxious stimuli

  2014cited by this paper
• In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects

  2014cited by this paper
• Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.

  2014influential reference
• Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

  2014cited by this paper
• The amygdala and medial prefrontal cortex: partners in the fear circuit

  2013cited by this paper
• Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

  2013cited by this paper
• Fear Extinction Induces mGluR5-Mediated Synaptic and Intrinsic Plasticity in Infralimbic Neurons

  2013cited by this paper
• Non-psychotropic analgesic drugs from the endocannabinoid system: "magic bullet" or "multiple-target" strategies?

  2013cited by this paper
• Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.

  2013cited by this paper
• Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid‐mediated fear‐conditioned analgesia in rats

  2013influential reference
• Prefrontal cortex and mediodorsal thalamus reduced connectivity is associated with spatial working memory impairment in rats with inflammatory pain

  2013cited by this paper
• Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.

  2013cited by this paper
• Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.

  2013influential reference
• Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1.

  2013influential reference
• The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.

  2013cited by this paper
• Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors.

  2013cited by this paper
• Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure

  2013cited by this paper
• Synaptic Mechanisms Underlying Strong Reciprocal Connectivity between the Medial Prefrontal Cortex and Basolateral Amygdala

  2013influential reference
• Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor

  2012influential reference
• Neural and cellular mechanisms of fear and extinction memory formation.

  2012cited by this paper
• An efficient randomised, placebo‐controlled clinical trial with the irreversible fatty acid amide hydrolase‐1 inhibitor PF‐04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

  2012cited by this paper
• The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone

  2012cited by this paper
• Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat

  2012cited by this paper
• Lack of effect of chronic pre‐treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system

  2012cited by this paper
• Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia

  2012influential reference
• O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.

  2012cited by this paper
• Multiple functions of endocannabinoid signaling in the brain.

  2012cited by this paper
• Medial prefrontal cortical innervation of the intercalated nuclear region of the amygdala.

  2012cited by this paper
• Dynamic changes to the endocannabinoid system in models of chronic pain

  2012cited by this paper
• Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects.

  2012cited by this paper
• Recent Advances in the Pharmacological Management of Pain

  2012cited by this paper
• The economic costs of pain in the United States.

  2012cited by this paper
• The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice

  2012cited by this paper
• Dissociable Roles of Prelimbic and Infralimbic Cortices, Ventral Hippocampus, and Basolateral Amygdala in the Expression and Extinction of Conditioned Fear

  2011cited by this paper
• Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain

  2011cited by this paper
• Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.

  2011cited by this paper
• Inhibition of Monoacylglycerol Lipase Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Hemorrhages in Mice

  2011cited by this paper
• Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain

  2011cited by this paper
• Different Fear States Engage Distinct Networks within the Intercalated Cell Clusters of the Amygdala

  2011cited by this paper
• Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons.

  2011influential reference
• The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats

  2011cited by this paper
• A FAAH-fetched approach to treat osteoarthritis pain.

  2011cited by this paper

• Sex differences in pain-related behaviour and the endocannabinoid system following hind limb ischemia-reperfusion injury.

  2026cites this paper
• Regular Cannabis Use is Associated with a Diminished Anandamide Response to a Standard Exercise Stimulus: A Pilot Study.

  2026cites this paper
• The Endocannabinoid System’s Contribution to Placebo Analgesia

  2026cites this paper
• Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025

  2026cites this paper
• Beyond the High: Therapeutic Insights into Cannabis Sativa and Endocannabinoid Control of Pain

  2026cites this paper
• Endocannabinoids, perioperative pain, and acetaminophen in patients undergoing total knee arthroplasty: a prospective cohort study

  2026cites this paper
• The Role of the Endocannabinoid System in the Mechanism of Action of Nonopioid Analgesics.

  2025cites this paper
• State of the Art Review: Thiazide diuretics exploit the endocannabinoid system via NAPE-PLD.

  2025cites this paper
• Spinal Glia-Driven Neuroinflammation as a Therapeutic Target for Neuropathic Pain: Rational Development of Novel Analgesics.

  2025cites this paper
• Sexually dimorphic cannabinoid 1 receptors on CaMKIIα neurons in the medial prefrontal cortex mediate sex differences in ACEA-induced antinociception in mice

  2025cites this paper
• Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis

  2025influential citation
• Early oral administration of THC:CBD formulations prevent pain-related behaviors without exacerbating paclitaxel-induced changes in weight, locomotion, and anxiety in a rat model of chemotherapy-induced neuropathy

  2025cites this paper
• Chronic inflammatory pain and chronic THC vapor inhalation alter midbrain neuronal activity.

  2025cites this paper
• Cannabis use frequency is associated with emotion dysregulation among persons receiving long-term opioid therapy for chronic pain: A psychophysiological study.

  2025cites this paper
• The Contribution of Baseline Circulating Endocannabinoids to Individual Differences in Human Pain Sensitivity: A Quantitative Sensory Testing Study

  2025cites this paper
• Investigation of endocannabinoids in plasma and their correlation with physical fitness and resting state functional connectivity of the periaqueductal grey in women with fibromyalgia: An exploratory secondary study

  2025cites this paper
• Terpenes as Modulators of Nociceptive Signaling: Behavioral and Molecular Insights from Caenorhabditis elegans

  2025cites this paper
• Long-Term Efficacy and Safety of Inhaled Cannabis Therapy for Painful Diabetic Neuropathy: A 5-Year Longitudinal Observational Study

  2025cites this paper
• MPN-12-NH2 shows potent antinociception effects by targeting opioid, cannabinoid, and neuropeptide FF receptors.

  2025cites this paper
• Advances in the Quest for Safe and Effective Drugs That Target the Cannabinoid Receptor Type 1 (CB1).

  2025cites this paper
• Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice

  2025cites this paper
• How Do Peripheral Neurons and Glial Cells Participate in Pain Alleviation by Physical Activity?

  2025cites this paper
• Acetaminophen inhibits diacylglycerol lipase synthesis of 2-arachidonoyl glycerol: Implications for nociception

  2025cites this paper
• FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders.

  2025cites this paper
• Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery.

  2025cites this paper
• Improvement in the Cognitive Function in Chronic Pain: Therapeutic Potential of the Endocannabinoid System

  2025cites this paper
• A cryptic pocket in CB1 drives peripheral and functional selectivity

  2025cites this paper
• Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain.

  2024cites this paper
• Targeting the endocannabinoid system for the management of low back pain.

  2024cites this paper
• Modulation of chemotherapy-induced peripheral neuropathy by JZL195 through glia and the endocannabinoid system.

  2024cites this paper
• Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone.

  2024cites this paper
• Characterization of a Fatty Acid Amide Hydrolase (FAAH) in Hirudo Verbana

  2024cites this paper
• Cannabinoid and Serotonergic Systems: Unraveling the Pathogenetic Mechanisms of Stress-Induced Analgesia

  2024cites this paper
• G Protein-Coupled Receptors and Ion Channels Involvement in Cisplatin-Induced Peripheral Neuropathy: A Review of Preclinical Studies

  2024cites this paper
• The Endocannabinoid System of the Nervous and Gastrointestinal Systems Changes after a Subnoxious Cisplatin Dose in Male Rats

  2024cites this paper
• Cannabidiol (CBD): Confronting consumers' expectations of therapeutic benefits with pharmacological reality.

  2024cites this paper
• Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways

  2024cites this paper
• The role of Cannabinoid receptors in visceral pain sensation of rat: an interventional study

  2024cites this paper
• Data-driven dynamic profiles of tonic heat pain perception in pain-free volunteers are associated with differences in anandamide levels

  2024cites this paper
• CCK+ Interneurons Contribute to Thalamus-Evoked Feed-Forward Inhibition in the Prelimbic Prefrontal Cortex

  2024cites this paper
• Δ9-Tetrahydrocannabinol Alleviates Hyperalgesia in a Humanized Mouse Model of Sickle Cell Disease

  2024cites this paper
• SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation

  2024cites this paper
• Effect of thymoquinone on acetic acid-induced visceral nociception in rats: role of central cannabinoid and α2-adrenergic receptors

  2024cites this paper
• Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1

  2024cites this paper
• Psychotropic Drugs Reemerging as Headache Medicines

  2024cites this paper
• Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson’s disease

  2024cites this paper
• Cannabis medicine for chronic pain

  2024cites this paper
• THC vapor inhalation attenuates hyperalgesia in rats using a chronic inflammatory pain model.

  2024cites this paper
• Assessing suicide risk in chronic pain management: a narrative review across drug classes

  2024cites this paper
• Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics

  2024cites this paper
• Sex-Specific Differences and the Role of Environmental Enrichment in the Expression of Hippocampal CB1 Receptors following Chronic Unpredictable Stress

  2024cites this paper
• Die Rolle von Cannabis für die Behandlung chronischer Schmerzen

  2024cites this paper
• Endocannabinoid System: Chemical Characteristics and Biological Activity

  2023cites this paper
• Chronic wound-related pain, wound healing and the therapeutic potential of cannabinoids and endocannabinoid system modulation.

  2023cites this paper
• Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls

  2023cites this paper
• Tolerance to cannabinoids in mice

  2023cites this paper
• Suppression of neuropathic pain in the circadian clock–deficient Per2m/m mice involves up-regulation of endocannabinoid system

  2023cites this paper
• The Endocannabinoid System and Physical Exercise

  2023cites this paper
• Differential Plasma Endocannabinoids and Cannabimimetic Fatty Acid Derivatives in the Transition From Acute to Chronic Low Back Pain: A Pilot Study

  2023cites this paper
• Cannabinoides y dolor PARTE I

  2023cites this paper
• Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System

  2023cites this paper
• Sex differences in stress‐induced hyperalgesia and its mechanisms

  2023cites this paper
• Novel Targets and Drug Delivery System in the Treatment of Postoperative Pain: Recent Studies and Clinical Advancement.

  2023cites this paper
• Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain

  2023cites this paper
• Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot study

  2023cites this paper
• Oxidative Stress in Substance Use Disorders: Endogenous and Exogenous Mechanisms of Repair

  2023cites this paper
• SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function

  2023cites this paper
• Impact of Δ9-Tetrahydrocannabinol and oxycodone co-administration on measures of antinociception, dependence, circadian activity, and reward in mice

  2023cites this paper
• Effects of Cannabidiol (CBD) on the inflammatory response of patients with rheumatoid arthritis.

  2023cites this paper
• A synergistic analgesic effect of morphine in combination with the CB1 receptor agonist, ACPA, in normal, hypothyroid, and hyperthyroid male rats.

  2023influential citation
• FAAH rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine

  2023cites this paper
• Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

  2023cites this paper
• ABHD6 and MAGL control 2-AG levels in the PAG and allodynia in a CSD-induced periorbital model of headache

  2023influential citation
• Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain

  2023cites this paper
• The Selective CB2 Agonist COR167 Reduced Symptoms in a Mice Model of Trauma-Induced Peripheral Neuropathy through HDAC-1 Inhibition

  2023cites this paper
• Integrative approach to the therapeutic use of cannabis for orofacial pain

  2023cites this paper
• Multimodaler Ansatz zum Verständnis des Zusammenspiels zwischen dem endokrinen und dem Endocannabinoidsystem, nicht suizidalem selbstverletzendem Verhalten und der Borderline-Persönlichkeitsstörung

  2023influential citation
• Chronic THC vapor inhalation rescues hyperalgesia in rats with chronic inflammation and produces sex-specific alterations in midbrain neuronal activity

  2023cites this paper
• Endogenous Inflammatory Mediators Produced by Injury Activate TRPV1 and TRPA1 Nociceptors to Induce Sexually Dimorphic Cold Pain That Is Dependent on TRPM8 and GFRα3

  2023cites this paper
• Endogenous inflammatory mediators produced by injury activate TRPV1 and TRPA1 nociceptors to induce sexually dimorphic cold pain that is dependent on TRPM8 and GFRα3

  2023cites this paper
• Association of FAAH rs324420 (C385A) Polymorphism with High-Level Performance in Volleyball Players

  2023cites this paper
• Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment

  2023cites this paper
• The mechanistic basis for the effects of electroacupuncture on neuropathic pain within the central nervous system.

  2023cites this paper
• Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain

  2022cites this paper
• Metabolomics analysis of plasma samples of patients with fibromyalgia and electromagnetic sensitivity using GC–MS technique

  2022cites this paper
• Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives

  2022cites this paper
• The Endogenous Cannabinoid System and Nitric Oxide Interact in Modulation of Cold Stress-induced Analgesia

  2022cites this paper
• Resultados preclínicos de cannabinoides y dolor (algunos)

  2022cites this paper
• Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.

  2022cites this paper
• Neuro-inflammation induite par une prise alimentaire incontrôlée : risque de douleurs chroniques ?

  2022cites this paper
• Endocannabinoid signaling in the central nervous system

  2022cites this paper
• Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  2022cites this paper
• Down-regulation of NR2B receptors contributes to the analgesic and antianxiety effects of enriched environment mediated by endocannabinoid system in the inflammatory pain mice.

  2022cites this paper
• Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) "Cis-On" Agonist.

  2022cites this paper
• In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice

  2022cites this paper
• Fatty acid amide hydrolase activity in the dorsal PAG attenuates neuropathic pain and associated dysautonomia.

  2022cites this paper
• Release of Endocannabinoids into the Cerebrospinal Fluid during the Induction of the Trigemino-Hypoglossal Reflex in Rats

  2022cites this paper
• New analgesics in cancer pain

  2022cites this paper
• Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain

  2022influential citation
• Mechanisms of bone pain: Progress in research from bench to bedside

  2022cites this paper